The FDA has approved the Enlite sensor for use with Medtronic’s iPro2 Professional Continuous Glucose Monitoring system, a disposable glucose sensor that can be worn for up to 6 days. The Enlite ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite™ Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 ...

Medtronic, Inc. (NYSE: MDT) today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite™ Sensor, the ...

Medtronic has announced FDA approval of the Enlite sensor with iPro2 Professional Continuous Glucose Monitoring (CGM) system. The sensor is a disposable glucose sensor. It provides the user with more ...

Medtronic plcMDT recently announced the receipt of the U.S. FDA approval for its Enlite sensor, which is to be used with the iPro2 Professional Continuous Glucose Monitoring (CGM) system. This is ...

With a great deal of hype, and a few delays from the US Food and Drug Administration (FDA), Medtronic in September 2013 released its newest combined pump and continuous glucose monitor (CGM), the ...

Medtronic plc MDT disclosed that the FDA has given its approval of the Enlite sensor for use with iPro2 Professional Continuous Glucose Monitoring (CGM) system. This is a market-leading CGM system, ...

MiniMed® 530G with Enlite Automatically Stops Insulin Delivery If Sensor Glucose Levels Fall Below a Predetermined Threshold MINNEAPOLIS - September 27, 2013 -Medtronic, Inc. (NYSE:MDT) today ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio BALTIMORE — Professional continuous ...

I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...

The continuous glucose monitoring market is dominated by the likes of Dexcom and Medtronic, to name a couple, but another company recently received a regulatory nod from the Food and Drug ...

With the unveiling of the first FDA-approved system with the name "artificial pancreas," Medtronic will seek a new CMS code that would cover both the insulin pump and the continuous glucose monitoring ...